Nateglinide Tablet, Film Coated
Product Images NDC 70771-1016

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Nateglinide (NDC 70771-1016). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

903d75f1 4cb2 46ee Bffb Cc18293f8f98 02

Nateglinide Tablets, USP 60 mg film-coated oral tablets packaging label by Zydus Lifesciences Limited. The label shows the NDC 70771-1015-9 and a count of 90 tablets in the container. It includes storage instructions, dosage note, and cautions to keep out of reach of children. The tablet imprint '721' is visible.*

FDA Label Image

903d75f1 4cb2 46ee Bffb Cc18293f8f98 03

Nateglinide Tablets, USP 120 mg film-coated oral tablets packaging label. The label shows a 120 mg strength with an image of an oblong tablet embossed with '722'. The label notes 90 tablets per container and indicates prescription use only. Manufactured by Cadila Healthcare Ltd. in Ahmedabad, India, and labeled by Zydus Lifesciences Limited.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.